28-Year-Old Woman with Hyperprolactinemia and Its Relationship to Polycystic Ovary Syndrome

    November 2023 in “ Manuju ”
    Ely Malihah, Diana Novitasari, A. R. Nasution, Mietha Apriyanti
    Image
    Studysummary This paper discusses the complex relationship between polycystic ovary syndrome (PCOS) and hyperprolactinemia, noting a decrease in prolactin levels following bromocriptine treatment, but reports no new clinical findings. Our plain-language summary of this paper — not a Tressless recommendation.
    This document discusses a 28-year-old woman with hyperprolactinemia and its relationship to Polycystic Ovary Syndrome (PCOS). PCOS is characterized by hyperandrogenism, menstrual irregularities, and ovarian cysts, and is often linked with hyperinsulinemia and insulin resistance. Symptoms include enlarged ovaries, irregular menstrual cycles, low back pain, hirsutism, alopecia, acne, and skin tags. Laboratory tests are essential to rule out other diagnoses and measure androgen levels. After treatment with bromocriptine, the patient's prolactin levels decreased, highlighting the importance of considering hyperprolactinemia in PCOS cases.
    Discuss this study in the Community →